In the BioHarmony Drug Report Database

"Preview" Icon

Norgestimate

Prefest (norgestimate) is a small molecule pharmaceutical. Norgestimate was first approved as Prefest on 1999-10-22. It is used to treat amenorrhea, female infertility, and uterine hemorrhage in the USA. It is known to target short transient receptor potential channel 3 and short transient receptor potential channel 6.

 

Trade Name

 

Prefest
 

Common Name

 

norgestimate
 

ChEMBL ID

 

CHEMBL1200934
 

Indication

 

amenorrhea, female infertility, uterine hemorrhage
 

Drug Class

 

Progestins

Image (chem structure or protein)

Norgestimate structure rendering